The role of glutathione in cancer

  title={The role of glutathione in cancer},
  author={Ganesaratnam Balendiran and Rajesh Dabur and D Fraser},
  journal={Cell Biochemistry and Function},
Glutathione is an abundant natural tripeptide found within almost all cells. Glutathione is highly reactive and is often found conjugated to other molecules via its sulfhydryl moiety. It instils several vital roles within a cell including antioxidation, maintenance of the redox state, modulation of the immune response and detoxification of xenobiotics. With respect to cancer, glutathione metabolism is able to play both protective and pathogenic roles. It is crucial in the removal and… 

Glutathione in Ovarian Cancer: A Double-Edged Sword

Insight is presented into the role of GSH in the poor prognosis of ovarian cancer, and how some strategies underlying the dependence of ovarian cancer cells on GSH can be further used to improve the effectiveness of therapy.

Glutathione in Cancer Biology and Therapy

An analysis of links among GSH, adaptive responses to stress, molecular mechanisms of invasive cancer cell survival and death, and sensitization of metastatic cells to therapy shows that acceleration of GSH efflux facilitates selective GSH depletion in metastasis cells.

Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance.

This review highlights the multifaceted roles of glutathion and glutathione-based systems in carcinogenesis, anticancer drug resistance, and clinical applications and suggests mechanism-based rational drug combinations that are directed against multiple redox targets using effective, specific, and clinically safe inhibitors are needed.

Glutathione in Cancer Cell Death

This review will finally analyze whether GSH depletion may facilitate cancer cell death under in vivo conditions, and how this can be applied to cancer therapy.

Heterogeneous Role of the Glutathione Antioxidant System in Modulating the Response of ESFT to Fenretinide in Normoxia and Hypoxia

The role of the GSH antioxidant system in modulating the sensitivity of Ewing's sarcoma family of tumours cells to fenretinide is heterogeneous depending on environment and cell type, likely to limit the value of targeting GSH as a therapeutic strategy to overcome hypoxia-induced drug resistance in ESFT.

Role of Glutathione in Cancer Progression and Chemoresistance

The present review highlights the role of GSH and related cytoprotective effects in the susceptibility to carcinogenesis and in the sensitivity of tumors to the cytotoxic effects of anticancer agents.

Elucidation of thioredoxin reductase 1 as an anticancer drug target

The ability to inhibit TrxR1 function with small molecule drug candidates, the role such inhibition has on modulating ROS levels, and whether such inhibition is sufficient to elicit anticancer therapeutic effects are examined.

The central role of glutathione in the pathophysiology of human diseases

The current state of knowledge on the role of GSH is reviewed to underscore its relevance in translational research for future therapeutic treatment design and to modulate redox-sensitive components of signal transduction cascades.

Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.

New data show that the major cellular antioxidant systems, the thioredoxin (Trx) and glutathione (GSH) systems, actually promote cancer growth and HIV infection, while suppressing an effective immune response.

An investigation into the role of transglutaminase 2 in the uptake of cisplatin in parental and chemoresistant cancer cells

It is indicated that the presence of elevated levels of TG2 in hepatocellular carcinoma prevents and/or limits the entry of anti-cancer drugs, and TG2 may represent a novel biomarker and possibly a therapeutic target for overcoming the chemotherapeutic resistance in hepatocarcinoma.



Glutathione conjugate mediated toxicities.

Cellular glutathione and thiols metabolism.

Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.

It is demonstrated that selective differential chemotherapy responses of normal versus tumor cells is possible by manipulating the GSH synthetic cycle and that manipulation in GSH levels might yield a therapeutic gain for carefully selected chemotherapy drugs.

Functions of glutathione and glutathione disulfide in immunology and immunopathology

It is proposed that the well‐known immunological consequences of GSH depletion ultimately may be results of the accompanying GSSG deficiency, and hypothesize that AIDS may be the consequence of a G SSG deficiency as well.

Parallel assessment of glutathione‐based detoxifying enzymes, O6‐alkylguanine‐dna alkyltransferase and P‐glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer

The findings indicate that the fundamental differences in chemo‐sensitivity between SCLC and NSCLC cannot be explained by differences in the GSH‐system or in the expression of Pgp, however, the level of ATase activity may be one of the factors responsible for the difference in chemosensitivity.

The glutathione status of cells.

Symposium overview: the role of glutathione in neuroprotection and neurotoxicity.

GSH and glutathione disulfide appear to play important functional roles in the central nervous system (CNS), and evidence was presented for a role for GSH conjugation in (+/-)-3,4- methylenedioxyamphetamine-mediated serotonergic neurotoxicity.